Outcome | Variable | Hazard ratio | 95% CI | P |
---|---|---|---|---|
Intracranial PFS | SRS and nivolumab | 0.54 | 0.32–0.92 | 0.038 |
fmulti-fraction SRS | 0.48 | 0.28–0.87 | 0.015 | |
OS | SRS and nivolumab | 0.51 | 0.28–0.81 | 0.019 |
multi-fraction SRS | 0.54 | 0.33–0.96 | 0.043 | |
KPS >70 | 0.34 | 0.23–0.78 | 0.010 | |
absent extracranial disease | 0.50 | 0.29–0.81 | 0.018 |